|
Dr. Bryan S. Finkle is a consultant in pre-clinical new drug
development and medico-legal toxicology. For ten
years, 1973-1983, Dr. Finkle was the Director of the Center for
Human Toxicology at the University of Utah, and from
1983-1989 was Director of the Department of Pharmacology Sciences
at Genentech, Inc. South San Francisco, California. During
this period he was Associate Professor of
Pharmacology-Toxicology in the College of Pharmacy, and Department
of Pathology in the College of Medicine, University of Utah
Health Sciences Center. Until 1996, Dr. Finkle was the Vice
President for Development and Regulatory Affairs at Canji, Inc., a
biotechnology company dedicated to gene therapy using tumor
suppressor genes, novel cancer therapeutics and diagnostics.
From 2000-02 he was associated with NewBiotics Inc., a
biotechnology company dedicated to the development of enzyme
catalyzed therapeutic agents. He continues to consult for medical
biotechnology companies.
He is educated in chemistry, pharmacology and toxicology and began
his career in forensic science at the Scotland Yard laboratory in
England (1956), specializing in toxicology. In 1964, he was
appointed Chief Forensic Toxicologist in Santa Clara County in San
Jose, California and later lectured in forensic toxicology at the
University of California of Criminology at Berkeley. He is
currently Chief Consulting Toxicologist to the National Football
League, and consultant to the World and U.S. Antidoping Agencies.
He is the President and Chairman of the Board for the Sports
Medicine Research and Testing Laboratory Inc. He serves on the
Board of the NFL Health Foundation; the Scientific Advisory Board
of the Partnership for Clean Competition, and consults with the
NFL-NFLPA Research and Education Foundation.
He is recipient of the Stas Medal, awarded by the German Society of
Toxicology and Chemistry and the Rolla Harger Award, an honor given
by the American Academy of Forensic Sciences, Toxicology Section.
In the fall of 1995 he received the Borkenstein Award from the
National Safety Council for his more than 25 years of work on the
role of alcohol and other drugs related to highway safety.
|